FR EA

Matter 1018-00008 — Penterra Pharmaceuticals Corp

2024 · 75 documents · M&A / Corporate · D. Lindqvist

235.2hours logged
$52,400unbilled WIP
$194,600billed to date
DateLawyerDescription HoursAmount
2025-06-17 S. Beaumont Review and annotate billing narrative fee summary 2.9 $3,045
2025-06-25 L. Marchetti Conference call re matter opening memo 2.6 $2,730
2025-06-25 P. Iyer Analyze matter status memo deal terminated 2.8 $2,940
2025-07-08 L. Marchetti Prepare staffing plan budget memo 2.6 $2,730
2025-07-19 L. Marchetti Draft and revise board presentation transaction summary 1.9 $1,995
2025-07-27 C. Fontaine Review and annotate board resolution spa execution 2.1 $2,205
2025-06-29 C. Fontaine Review and annotate officers certificate penterra form 3.3 $3,465
2025-07-01 J. Whitfield Review and annotate secretarys certificate penterra 4.4 $4,620
2025-08-20 J. Whitfield Correspondence re stockholder consent process memo 0.9 $945
2025-07-23 A. Nakamura Legal research re email chu to pratt deficiency followup 3.1 $3,255
2025-09-05 P. Iyer Draft and revise tax dd memo 2.8 $2,940
2025-07-31 D. Lindqvist Conference call re corporate dd memo 4.3 $4,515
2025-08-04 R. Okafor Legal research re dd summary memo to board 1.4 $1,470
2025-09-16 R. Okafor Review and annotate employment benefits dd memo 3.9 $4,095
Invoice preview 235.2 $52,400